Incidence of dementia · People with MCI/prodromal AD
Souvenaid showed no clear difference in incidence of dementia compared with placebo (moderate certainty).
1 finding from 1 review
Executive function (specific cognitive function) · People with mild Alzheimer's disease
1 finding from 1 review
Functional outcomes · People with mild Alzheimer's disease
1 finding from 1 review
Quality of life · People with mild Alzheimer's disease
1 finding from 1 review
Combined cognitive‐functional outcome · People with mild Alzheimer's disease
1 finding from 1 review
Any adverse events · People with mild Alzheimer's disease
Souvenaid showed no clear difference in any adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Cognitive function · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Memory (specific cognitive function) · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Executive function (specific cognitive function) · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Activities of daily living · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Quality of life, · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Cognitive function · People with MCI/prodromal AD
1 finding from 1 review
Combined cognitive‐functional outcome · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Any adverse events · Apathy in people with mild‐to‐moderate Alzheimer's disease
Souvenaid showed no clear difference in any adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Memory (specific cognitive function) · People with MCI/prodromal AD
1 finding from 1 review
Executive function (specific cognitive function) · People with MCI/prodromal AD
1 finding from 1 review
Functional outcomes · People with MCI/prodromal AD
1 finding from 1 review
Combined cognitive‐functional outcome · People with MCI/prodromal AD
1 finding from 1 review
Any adverse event · People with MCI/prodromal AD
Souvenaid showed no clear difference in any adverse event compared with placebo (moderate certainty).
1 finding from 1 review
Cognitive function · People with mild Alzheimer's disease
1 finding from 1 review